Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare    

Pharmaceuticals Market

PRODUCT TITLE PUBLISHED
Agents for treatment of hemorrhoids and anal fissures for topical use Agents for treatment of hemorrhoids and anal fissures for topical use
Agents for treatment of hemorrhoids and anal fissures for topical use and its peer markets - Immunoassay,
Upcoming
Cytotoxic antibiotics and related substances Cytotoxic antibiotics and related substances
Cytotoxic antibiotics and related substances and its peer markets - Proteomics,
Upcoming
Global Live Attenuated Vaccines (LAV) Market Global Live Attenuated Vaccines (LAV) Market
The Global Live Attenuated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $2515 million in 2013 and expected to be $3633 million by 2018 at a CAGR of 7.6%. Live Attenuated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Inactivated Vaccines Market Global Inactivated Vaccines Market
The Global Inactivated Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $1958 million in 2013 and expected to be $2974million by 2018 at a CAGR of 8.7%. Inactivated Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Sub-unit Vaccines Market Global Sub-unit Vaccines Market
The Global Subunit Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $91 million in 2013 and expected to be $134 million by 2018 at a CAGR of 8.1%. Subunit Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Toxoid Vaccines Market Global Toxoid Vaccines Market
The Global Toxoid Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $468.1 million in 2013 and expected to be $644.8 million by 2018 at a CAGR of 6.6%. Toxoid Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Conjugate Vaccines Market Global Conjugate Vaccines Market
The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Global Recombinant Vaccines Market Global Recombinant Vaccines Market
The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Dna Vaccines Market Global Dna Vaccines Market
The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Animal Vaccines Animal Vaccines
Animal Vaccines and Bacterial vaccines, Viral vaccines,
Upcoming
Synthetic Vaccines Synthetic Vaccines
Synthetic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Dentritic Vaccines Dentritic Vaccines
Dentritic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
X-Ray Contrast Media X-Ray Contrast Media
X-Ray Contrast Media and Magnetic resonance imaging contrast media,
Upcoming
Barium-based contrast media Barium-based contrast media
Barium-based contrast media and Iodinated contrast media and
Upcoming
Iodinated contrast media Iodinated contrast media
Iodinated contrast media and Barium-based contrast media and
Upcoming
Gadolinium-based contrast media Gadolinium-based contrast media
Gadolinium-based contrast media and Barium-based contrast media and
Upcoming
Acute myeloid leukemia (AML) Acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) and its peer markets - Burkitt lymphoma,
Upcoming
Acute lymphoblastic leukemia (ALL) Acute lymphoblastic leukemia (ALL)
Acute lymphoblastic leukemia (ALL) and its peer markets - T-cell Lymphoma,
Upcoming
Chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML) and its peer markets - Hodgkin lymphoma,
Upcoming
Chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia (CLL)
Chronic lymphocytic leukemia (CLL) and its peer markets - T-cell Lymphoma,
Upcoming
812 reports | Show
Connect With Us
US/CAN : +1-888-502-0539